Vivozon Pharmaceutical Co., Ltd. (082800)
Market Closed
11 Aug, 06:01
KRX SM KRX SM Primary ₩
2,950. 00
+85
+2.9668%
₩
140.43B Market Cap
- P/E Ratio
23.06% Div Yield
192,094 Volume
- Eps
₩ 2,865
Previous Close Want to track 082800 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vivozon Pharmaceutical Co., Ltd. (082800) Statistics
Valuation metrics
Market Cap 140.43B
Enterprise value 179.64B
Trailing P/E (ttm) -17.29
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 2.37
Price/Book (mrq) 2.04
Enterprise Value/Revenue 3.03
Enterprise Value/EBITDA -9.42
Overview
Shares outstanding 60.36M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 844.88K
Average volume (90 days) 502.68K
Price summary
52-Week low 2,070
52-Week high 8,470
Beta -
50-Day moving average 3,205.9
200-Day moving average 4,866.18
Dividends and splits
Forward annual dividend rate 23.06
Forward annual dividend yield 0.0086%
Trailing annual dividend rate 18.52
Trailing annual dividend yield 0.0069%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 23 Mar 2022
Ex-Dividend Date 16 Mar 2022
Last split factor 1:5
Last split Date 24 Nov 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.41%
Operating margin -0.51%
Operational effectiveness
Return on assets -0.2%
Return on equity -0.45%
Income Statement
Revenue (ttm) 59.34B
Revenue per share (ttm) 1,741.39
Quarterly revenue growth (yoy) -0.13%
Gross profit (ttm) 24.18B
EBITDA 899.79M
Net income to common (ttm) -32.42B
Diluted EPS (ttm) -198.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 42.34B
Total Debt/Equity (mrq) 0.58
Current ratio (mrq) 0.43%
Book value per share (mrq) 1,679.93
Cash Flow
Cash flow statement -15.77B
Levered free cash flow (LFCF) -32.42B
